Hla Drb1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Protein Name | MHC Class II DR Beta 1 Chain |
|---|
| Gene Symbol | HLA-DRB1 |
|---|
| UniProt ID | P01911 |
|---|
| Molecular Weight | ~30 kDa |
|---|
| Subcellular Localization | Plasma membrane, Endosomal compartment |
|---|
| Protein Family | MHC Class II beta chain family |
|---|
HLA-DRB1 encodes the beta chain of the HLA-DR heterodimer, a major histocompatibility complex (MHC) class II molecule. HLA-DRB1 is critical for adaptive immune responses, presenting peptide antigens to CD4+ T cells. Genetic variants in HLA-DRB1 have been associated with late-onset Alzheimer's disease (LOAD), linking immune system genetics to neurodegeneration.[1]
HLA-DRB1 is a type I transmembrane glycoprotein with characteristic MHC class II structure:
- Alpha Helices: Two alpha helices form the peptide-binding groove
- Beta Sheet: Seven beta strands form the floor of the peptide-binding groove
- Peptide-Binding Groove: Open-ended groove that accommodates peptides of 13-25 amino acids
- Transmembrane Region: Hydrophobic transmembrane helix for membrane anchoring
- Cytoplasmic Tail: Short cytoplasmic domain for intracellular signaling
The peptide-binding groove is polymorphic, with different HLA-DRB1 alleles having distinct peptide-binding repertoires.
HLA-DRB1 is essential for adaptive immunity:
- Forms heterodimer with HLA-DRA alpha chain to present peptide antigens to CD4+ T cells[2]
- Peptide binding is determined by the allelic variant of HLA-DRB1
- Critical for initiating adaptive immune responses
- Different HLA-DRB1 alleles confer susceptibility or resistance to autoimmune diseases
- HLA-DRB1*15:01 is associated with increased risk of multiple sclerosis
- Shared epitope (SE) alleles are risk factors for rheumatoid arthritis
- Expressed at low levels on microglia in normal brain
- Upregulated in inflammatory conditions
- May present brain-derived antigens in AD and MS
HLA-DRB1, particularly the HLA-DRB1*15:01 allele, has been consistently associated with LOAD risk through GWAS.[1][3]
Disease Mechanisms:
- Microglial Activation: HLA molecules present antigens in the brain, potentially modulating responses to Aβ and tau pathology[4]
- Autoimmunity: Some HLA-DRB1 variants may predispose to autoimmune responses that cross-react with brain antigens
- Chronic Inflammation: Sustained HLA-DRB1-mediated immune responses may contribute to neuroinflammation
HLA-DRB1*15:01 is one of the strongest genetic risk factors for MS.
HLA-DRB1 alleles containing the shared epitope motif are major risk factors.
HLA-DRB1-based strategies:
- Immunomodulation: Understanding HLA-DRB1 associations may guide immunotherapy
- Personalized Medicine: HLA-DRB1 genotyping may predict treatment responses
- Autoimmunity Prevention: Insights may inform prevention strategies
- HLA-DRB1 and AD risk - Nat Neurosci (2013)
- HLA-DRB1*15:01 and AD - JAMA Neurol (2013)
- MHC class II in AD brain - Brain Pathol (2014)
The study of Hla Drb1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] HLA-DRB1 in Alzheimer disease. PMID:24162737
References
[1] Lambert JC, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013;45(12):1452-1458.
[2] Janeway CA, et al. Immunobiology: The Immune System in Health and Disease. 5th edition. Garland Science; 2001.
[3] Craig D, et al. HLA-DRB1*15:01 status and age at onset of Alzheimer's disease. JAMA Neurol. 2013;70(10):1321-1322.
[4] Wood WE, et al. MHC class II expression in the brain: implications for Alzheimer's disease. Brain Pathol. 2014;24(4):345-356.
HLA-DRB1 encodes the β chain of HLA-DR, a Major Histocompatibility Complex (MHC) class II molecule:
- Antigen presentation: Presents peptide antigens to CD4+ T cells
- Peptide binding: The DRβ1 chain determines peptide binding specificity
- Gene polymorphism: Extremely polymorphic with >600 alleles
- Expression: On antigen-presenting cells (B cells, macrophages, dendritic cells)
HLA-DR is essential for:
- Adaptive immunity: CD4+ T cell activation
- Immune regulation: T cell help for antibody production
- Autoimmunity: Risk for autoimmune diseases
- Alzheimer's disease: HLA-DR expression associated with microglial activation; some alleles protective
- Parkinson's disease: HLA-DRB1 alleles affect PD risk
- MS: HLA-DRB1*15:01 is major risk allele
- Therapeutic: Modulating antigen presentation